Eidogen-Sertanty Licenses Discovery Informatics Software and Databases to Cephalon
News Jan 06, 2006
Eidogen-Sertanty, Inc. has announced that Cephalon, Inc. will access Eidogen-Sertanty's Kinase Knowledgebase (KKB™), Target Informatics Platform™ (TIP™), and EVE™ Comparative Visualization software.
Scientists at Cephalon will use the proprietary software to support small molecule drug discovery projects in their neurology and oncology therapeutic programs.
"We are pleased to provide Cephalon with broad access to several of our discovery informatics products," said Dr. Steve Muskal, CEO of Eidogen-Sertanty.
"We're confident that our kinase informatics and structural informatics solutions will help the experienced research team at Cephalon accelerate their lead discovery efforts."
Chemical Compound Class Possesses Potential for Treating Zika VirusNews
A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study.READ MORE
Lab Innovations 2018 – Registration Opens and Keynotes AnnouncedNews
Learn and earn CPD points at the UK’s only lab-dedicated showcase and scientific seminar series.READ MORE